If a COVID-19 vaccine is to reach the global public sometime next year, it will be the result of one of the fastest developments and rollouts of a vaccine against a new disease ever. In contrast, the RTS,S malaria vaccine, which is currently undergoing its first nationwide pilot trials, was first developed over 30 years ago. But once these COVID-19 vaccines have been through clinical trials, what has to happen next before they can be used?
Ethiopia has overtaken Nigeria to become the Gavi-eligible African country most affected by COVID-19. Over the past week, the number of confirmed cases in Ethiopia has grown exponentially. Despite the pandemic, immunisation activities – both routine and campaign – are ongoing in Ethiopia.
As CEO of Gavi, the Vaccine Alliance funded largely by Bill Gates, Dr Seth Berkley has helped vaccinate almost half the world’s children from fatal and debilitating diseases. His current baby is the COVAX Facility to help develop, manufacture and secure doses of Covid-19 vaccines for 92 low and middle-income economies, including India. He speaks to Bachi Karkaria on the hope and hurdles.
As COVID-19 vaccines have a critical role to play in ending this pandemic crisis, many experts have described them as a global public good. But what exactly does that mean?
You may have heard the saying, “no products, no programs,” but for those who work in public health during COVID-19, the saying has become “no PPE, no programs.” And for community health workers (CHWs) who play a vital role in providing health care services to their communities, they face the danger of “no PPE, no safety.”
Scientists around the world are working at an unprecedented pace to test different types of vaccines that could help to stop the spread of COVID-19.
Many of the infections that can lead to sepsis are becoming resistant to antibiotics, which means that preventing them by vaccination is critical.
Antibodies are one route to immunity against disease, but T cells and innate immunity also play a crucial role in protecting us. So, how could these different types of immunity be mobilised against COVID-19
More than 3,000 health workers are conducting a three-day health campaign from 30 August to 1 September 2020 to ensure that around 400,000 children aged under five receive measles and polio vaccines, as well as vitamin A and deworming tablets, at fixed and outreach sites.